Prevymis (letermovir) - Merck (MSD)
Precision immune-guided management of cytomegalovirus (CMV) after allogeneic haematopoietic stem cell transplantation in the letermovir era: A pragmatic framework. (PubMed, Br J Haematol) - Jan 15, 2026 - No abstract available 
Journal • Cytomegalovirus Infection • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/41536163
 
Huafang Wang; Xinyi Jiang; Ziwei Xu
 
Jan 15, 2026
 
Prev Next